Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:08 PM
Ignite Modification Date:
2025-12-24 @ 7:08 PM
NCT ID:
NCT02517957
Eligibility Criteria:
Inclusion Criteria:
* accord with standard of syndrome differentiation of traditional Chinese medicine (blood hot sheng) and western medicine diagnostic criteria (subacute eczema);
* age between 18-65 years old, gender, ethnic unlimited;
* agreed to participate in clinical trials can observe and cooperate with the visitor on schedule;
* volunteered for this study and obtain informed consent will be;
* lesion area of about 5-30% of surface area (BSA) were (containing 3% and 3%, palm measurement method)
* IGA scale of 1 to 3 points (including);
* her lesions mainly located in the trunk and limbs (or);
* Women HCG negative;
Exclusion Criteria:
* known to the study of drug allergy to any of the components;
* previous or current with any may affect the results of systemic disease, or other activity of skin diseases (such as: psoriasis);
* has a liver and kidney function is not complete, liver damage of ALT and AST \> 1.5 times the upper limit of normal, renal BUN \> 1.5 times the upper limit of normal or creatinine \> 1.5 times the upper limit of normal value;
* QTcB or QTcF acuity 450 milliseconds. For subjects QTc acuity bundle branch block 480 milliseconds.
* prior or current with clinical significance of cardiovascular, lung disease, gastrointestinal tract, liver, kidney, blood, nerve abnormalities or mental disease;
* breast-feeding or plan to pregnant women during test;
* skin area score \> 30%;
* eosinophil count score \> 10%
* for nearly two weeks taking corticosteroids or a week, both inside and outside with corticosteroid preparation;
* three months received study medication or other participated in other clinical subjects;
* for any reason cannot cooperate research, for example: how language understanding, not to research centers, etc.;
* Researchers believe can bring obvious risk patients or confuse the results of the study, which should rule out other conditions or disease.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT02517957
Study Brief:
Protocol Section:
NCT02517957